|
| |
WORKING WITH ADVOCACY
GROUPS IN COALITIONS
Patient advocacy groups and professional associations within and across therapeutic areas often work together in coalitions to advance common goals. What is an appropriate role for pharmaceutical companies to play in these coalitions? The Fall 2013 Edition of STAR: Successfully Targeting Advocacy Relations
surveyed patient advocacy groups and professional associations across 15 therapeutic areas about their experiences and views on working in coalitions.
|
 |
To get your copy of the full 2013 STAR Report,
 or Contact: |
|
 |
The data reveal that a large majority of organizations – 87% – have been members of three or more coalitions in the past three years. Most of these coalitions are focused on disease awareness and education, policy action, and advocacy group support. In addition, panelists believe there are many appropriate roles for pharmaceutical companies to play in coalitions, including providing financial support, connecting organizations together, and providing resources.
The report also reveals:
- Most common role pharmaceutical companies play in coalitions
- Most common healthcare stakeholders that are members of coalitions
- How panelists view pharma's role in their coalitions
- Factors that contribute to the success and failure of coalitions
- The ideal source of financial support for coalitions
- Examples of effective coalitions
|
|
|
|
|
|
